Kymera Therapeutics (NASDAQ:KYMR) Trading Down 4.5%

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) dropped 4.5% during mid-day trading on Monday . The company traded as low as $19.05 and last traded at $19.05. Approximately 8,331 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 539,488 shares. The stock had previously closed at $19.95. […]

Related Keywords

Hong Kong ,Canada ,Piper Sandler ,Leerink Partnrs ,Credit Suisse Group ,Royal Bank ,Nasdaq ,Advisors Asset Management Inc ,Hong Kong Ltd ,Tower Research Capital ,Kymera Therapeutics Inc ,Morgan Stanley ,Kymera Therapeutics Company Profile ,Kymera Therapeutics ,Get Free Report ,Suisse Group ,Director Bvf Partners ,Kong Ltd ,Asset Management ,Research Capital ,Kymera Therapeutics Daily ,Nasdaq Kymr ,Kymr ,Medical ,Stocks ,Technicals ,